Phosphotyrosine profiling of human cerebrospinal fluid

Abstract

BackgroundCerebrospinal fluid (CSF) is an important source of potential biomarkers that affect the brain. Biomarkers for neurodegenerative disorders are needed to assist in diagnosis, monitoring disease progression and evaluating efficacy of therapies. Recent studies have demonstrated the involvement of tyrosine kinases in neuronal cell death. Thus, neurodegeneration in the brain is related to altered tyrosine phosphorylation of proteins in the brain and identification of abnormally phosphorylated tyrosine peptides in CSF has the potential to ascertain candidate biomarkers for neurodegenerative disorders.MethodsIn this study, we used an antibody-based tyrosine phosphopeptide enrichment method coupled with high resolution Orbitrap Fusion Tribrid Lumos Fourier transform mass spectrometer to catalog tyrosine phosphorylated peptides from cerebrospinal fluid. The subset of identified tyrosine phosphorylated peptides was also validated using parallel reaction monitoring (PRM)-based targeted approach.ResultsTo date, there are no published studies on global profiling of phosphotyrosine modifications of CSF proteins. We carried out phosphotyrosine profiling of CSF using an anti-phosphotyrosine antibody-based enrichment and analysis using high resolution Orbitrap Fusion Lumos mass spectrometer. We identified 111 phosphotyrosine peptides mapping to 66 proteins, which included 24 proteins which have not been identified in CSF previously. We then validated a set of 5 tyrosine phosphorylated peptides in an independent set of CSF samples from cognitively normal subjects, using a PRM-based targeted approach.ConclusionsThe findings from this deep phosphotyrosine profiling of CSF samples have the potential to identify novel disease-related phosphotyrosine-containing peptides in CSF.Electronic supplementary materialThe online version of this article (10.1186/s12014-018-9205-1) contains supplementary material, which is available to authorized users.

Altered Tyrosine Phosphorylation of Cardiac Proteins Prompts Contractile Dysfunction in Hypertrophic Cardiomyopathy

“…This data set indicates that a comparable yield of peptide identification was achieved, reproducibility on the enrichment of pTyr peptides, and high-quality MS/MS data using similar approaches to others [18][19][20] .…”

FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes

“…A possible FAM20C activity on neuropeptides of the secretory pathway has been reported in the nervous and endocrine systems. A great number of neuropeptides and pro-hormone precursors undergo phosphorylation as an important modification to modulate their activity [ 108 , 109 ]. These span a high number of peptides at dense core secretory vesicles in the lumen of Golgi that have FAM20C S-X-E/pS phosphosite motifs, which are phosphorylated at various degrees, and include prohormone-derived phosphopeptides.…”

Proteomics Landscape of Alzheimer’s Disease

“…These proteins have been taken forward for validation of potential biomarkers on a large number of samples using a targeted proteomics approach [ 52 , 53 ]. Attempts have also been made toward the identification of secretary post-translationally modified proteins in CSF as markers for AD [ 54 ]. Further, a meta-analysis of CSF proteomics studies by Pedrero-Prieto et al identified a panel of 27 proteins and 21 peptides highly altered in AD with consistent expression at least across three studies [ 55 ].…”